144 related articles for article (PubMed ID: 29588066)
1. Life-Threatening Everolimus-Associated Pneumonitis: A Case Report and a Review of the Literature.
Almeida F; Amorim S; Sarmento A; Santos L
Transplant Proc; 2018 Apr; 50(3):933-938. PubMed ID: 29588066
[TBL] [Abstract][Full Text] [Related]
2. Late Pulmonary Toxicity Associated With Everolimus in a Renal Transplant Patient and Review of the Literature.
Velioglu A; Eryuksel E; Cimsit C; Tuglular S; Ozener C
Exp Clin Transplant; 2018 Aug; 16(4):491-494. PubMed ID: 27001620
[TBL] [Abstract][Full Text] [Related]
3. [mTOR-induced pneumonitis in a 72-year-old patient after heart transplantation].
Kasper P; Göbel H; Michels G
Dtsch Med Wochenschr; 2020 Feb; 145(3):189-194. PubMed ID: 32018295
[TBL] [Abstract][Full Text] [Related]
4. Early everolimus-induced pneumonitis in a renal transplant recipient: A case report.
Sułkowska K; Palczewski P; Miszewska-Szyszkowska D; Durlik M; Gołębiowski M; Małkowski P
Ann Transplant; 2012 Dec; 17(4):144-8. PubMed ID: 23274336
[TBL] [Abstract][Full Text] [Related]
5. Fatal acute pulmonary injury associated with everolimus.
Depuydt P; Nollet J; Benoit D; Praet M; Caes F
Ann Pharmacother; 2012 Mar; 46(3):e7. PubMed ID: 22333263
[TBL] [Abstract][Full Text] [Related]
6. Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma.
White DA; Camus P; Endo M; Escudier B; Calvo E; Akaza H; Uemura H; Kpamegan E; Kay A; Robson M; Ravaud A; Motzer RJ
Am J Respir Crit Care Med; 2010 Aug; 182(3):396-403. PubMed ID: 20194812
[TBL] [Abstract][Full Text] [Related]
7. Everolimus-associated pneumonitis in 3 heart transplant recipients.
Otton J; Hayward CS; Keogh AM; Glanville AR; Macdonald PS
J Heart Lung Transplant; 2009 Jan; 28(1):104-6. PubMed ID: 19134540
[TBL] [Abstract][Full Text] [Related]
8. Interstitial pneumonitis caused by everolimus: a case-cohort study in renal transplant recipients.
Baas MC; Struijk GH; Moes DJ; van den Berk IA; Jonkers RE; de Fijter JW; van der Heide JJ; van Dijk M; ten Berge IJ; Bemelman FJ
Transpl Int; 2014 May; 27(5):428-36. PubMed ID: 24484452
[TBL] [Abstract][Full Text] [Related]
9. Everolimus-induced pneumonitis in neuroendocrine neoplasms: correlation of CT findings and clinical signs.
Fehrenbach U; Rodríguez-Laval V; Jann H; Fernández CMP; Pavel M; Denecke T
Acta Radiol; 2021 Aug; 62(8):1006-1015. PubMed ID: 32819165
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus and everolimus induced pneumonitis in adult renal allograft recipients: experience in a center.
Rodríguez-Moreno A; Ridao N; García-Ledesma P; Calvo N; Pérez-Flores I; Marques M; Barrientos A; Sánchez-Fructuoso AI
Transplant Proc; 2009; 41(6):2163-5. PubMed ID: 19715862
[TBL] [Abstract][Full Text] [Related]
11. Drug-related pneumonitis during mammalian target of rapamycin inhibitor therapy in patients with neuroendocrine tumors: a radiographic pattern-based approach.
Nishino M; Brais LK; Brooks NV; Hatabu H; Kulke MH; Ramaiya NH
Eur J Cancer; 2016 Jan; 53():163-70. PubMed ID: 26760924
[TBL] [Abstract][Full Text] [Related]
12. Characterization of pneumonitis in patients with advanced non-small cell lung cancer treated with everolimus (RAD001).
White DA; Schwartz LH; Dimitrijevic S; Scala LD; Hayes W; Gross SH
J Thorac Oncol; 2009 Nov; 4(11):1357-63. PubMed ID: 19745764
[TBL] [Abstract][Full Text] [Related]
13. Everolimus-induced pneumonitis associates with favourable outcome in patients with metastatic renal cell carcinoma.
Penttilä P; Donskov F; Rautiola J; Peltola K; Laukka M; Bono P
Eur J Cancer; 2017 Aug; 81():9-16. PubMed ID: 28586749
[TBL] [Abstract][Full Text] [Related]
14. Resolution of sirolimus-induced pneumonitis after conversion to everolimus.
Rehm B; Keller F; Mayer J; Stracke S
Transplant Proc; 2006 Apr; 38(3):711-3. PubMed ID: 16647451
[TBL] [Abstract][Full Text] [Related]
15. Severe everolimus-associated pneumonitis in a renal transplant recipient.
Alexandru S; Ortiz A; Baldovi S; Milicua JM; Ruíz-Escribano E; Egido J; Plaza JJ
Nephrol Dial Transplant; 2008 Oct; 23(10):3353-5. PubMed ID: 18658177
[TBL] [Abstract][Full Text] [Related]
16. Recommendations of everolimus use in liver transplant.
Rubín Suárez A; Bilbao Aguirre I; Fernández-Castroagudin J; Pons Miñano JA; Salcedo Plaza M; Varo Pérez E; Prieto Castillo M
Gastroenterol Hepatol; 2017 Nov; 40(9):629-640. PubMed ID: 28743539
[TBL] [Abstract][Full Text] [Related]
17. [Everolimus-associated pneumonitis in adult liver transplant recipient].
Marín-Gómez LM; Cordero-Matía E; Gómez-Bravo MÁ; Bernal-Bellido C
Med Clin (Barc); 2010 Sep; 135(9):431-2. PubMed ID: 19819477
[No Abstract] [Full Text] [Related]
18. Malignancy After Heart Transplantation Under Everolimus Versus Mycophenolate Mofetil Immunosuppression.
Wang YJ; Chi NH; Chou NK; Huang SC; Wang CH; Wu IH; Yu HY; Chen YS; Tsao CI; Shun CT; Tsai JT; Wang SS
Transplant Proc; 2016 Apr; 48(3):969-73. PubMed ID: 27234781
[TBL] [Abstract][Full Text] [Related]
19. Everolimus-Induced Systemic Serositis After Simultaneous Liver and Kidney Transplantation: A Case Report.
Kim K; Jeong DW; Lee YH; Kim YG; Moon JY; Jeong KH; Lee TW; Ihm CG; Joo SH; Park HC; Lee SH
Transplant Proc; 2017; 49(1):181-184. PubMed ID: 28104132
[TBL] [Abstract][Full Text] [Related]
20. A case of pneumocystis pneumonia associated with everolimus therapy for renal cell carcinoma.
Saito Y; Nagayama M; Miura Y; Ogushi S; Suzuki Y; Noro R; Minegishi Y; Kimura G; Kondo Y; Gemma A
Jpn J Clin Oncol; 2013 May; 43(5):559-62. PubMed ID: 23423809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
